These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 36225561)
1. Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation. Gou Q; Liu Z; Xie Y; Deng Y; Ma J; Li J; Zheng H Front Pharmacol; 2022; 13():995555. PubMed ID: 36225561 [No Abstract] [Full Text] [Related]
2. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer. Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247 [TBL] [Abstract][Full Text] [Related]
3. The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs. Pan W; Song K; Zhang Y; Yang C; Zhang Y; Ji F; Zhang J; Shi J; Wang K Front Immunol; 2022; 13():982486. PubMed ID: 36119101 [TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer. Li W; Zhang X; Chen Y; Pang D Front Oncol; 2022; 12():966511. PubMed ID: 36212436 [TBL] [Abstract][Full Text] [Related]
5. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma. Liu Z; He J; Han J; Yang J; Liao W; Chen N Front Immunol; 2021; 12():762243. PubMed ID: 35069534 [TBL] [Abstract][Full Text] [Related]
6. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response. Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356 [TBL] [Abstract][Full Text] [Related]
7. m Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750 [TBL] [Abstract][Full Text] [Related]
8. Homologous recombination deficiency in triple-negative breast cancer: Multi-scale transcriptomics reveals distinct tumor microenvironments and limitations in predicting immunotherapy response. Kang K; Wu Y; Han C; Wang L; Wang Z; Zhao A Comput Biol Med; 2023 May; 158():106836. PubMed ID: 37031511 [TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature. Qin Y; Deng J; Zhang L; Yuan J; Yang H; Li Q Aging (Albany NY); 2021 Feb; 13(4):5485-5505. PubMed ID: 33536349 [TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
11. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment. Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z Front Immunol; 2021; 12():691811. PubMed ID: 34489938 [TBL] [Abstract][Full Text] [Related]
12. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer. Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165 [TBL] [Abstract][Full Text] [Related]
13. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. Cheng T; Wu Y; Liu Z; Yu Y; Sun S; Guo M; Sun B; Huang C Front Immunol; 2022; 13():970950. PubMed ID: 36052076 [TBL] [Abstract][Full Text] [Related]
14. Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio. Liu J; Deng Y; Liu Z; Li X; Zhang M; Yu X; Liu T; Chen K; Li Z Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512096 [No Abstract] [Full Text] [Related]
15. Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma. Liu Z; He J; Hu X Front Genet; 2022; 13():975190. PubMed ID: 36118882 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer. Liu Z; Ding M; Qiu P; Pan K; Guo Q Front Immunol; 2023; 14():1200282. PubMed ID: 37520534 [TBL] [Abstract][Full Text] [Related]
17. Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies. Wu Q; Tian R; He X; Liu J; Ou C; Li Y; Fu X Front Immunol; 2023; 14():1164408. PubMed ID: 37090728 [TBL] [Abstract][Full Text] [Related]
18. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients. Geng S; Fu Y; Fu S; Wu K Front Immunol; 2022; 13():927565. PubMed ID: 36059555 [TBL] [Abstract][Full Text] [Related]
19. Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC. Xie J; Zheng S; Zou Y; Tang Y; Tian W; Wong CW; Wu S; Ou X; Zhao W; Cai M; Xie X Front Immunol; 2022; 13():1022147. PubMed ID: 36275659 [TBL] [Abstract][Full Text] [Related]
20. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma. Zhang W; Yao S; Huang H; Zhou H; Zhou H; Wei Q; Bian T; Sun H; Li X; Zhang J; Liu Y Oncoimmunology; 2021; 10(1):1959977. PubMed ID: 34527427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]